Literature DB >> 19781744

Percutaneous nephrolithotomy can be safely performed in the high-risk patient.

Sutchin R Patel1, George E Haleblian, Gyan Pareek.   

Abstract

OBJECTIVES: To determine whether percutaneous nephrolithotomy (PCNL) can be safely performed in the high-risk patient.
METHODS: The records of 84 patients undergoing 98 consecutive PCNL procedures from January 2005 to January 2007 at a single institution were examined. Patients were divided into a high-risk preoperative group, which comprised patients having American Society of Anesthesiologist scores of III or IV (n = 25) and a low-risk preoperative group of patients with an American Society of Anesthesiologist score of II or less (n = 59).
RESULTS: A total of 33 and 65 procedures were performed in the high- and low-risk groups, respectively. The high-risk group had significantly more comorbidities than the low-risk group (5.4 vs 1.5) (P <.001). No significant difference was noted in the mean cumulative stone size for single or multiple stones in either group. A significant difference was observed between the average anesthesia time (45 vs 25 minutes) and average length of hospital stay (4.0 +/- 3.5 vs 2.7 +/- 1.2 days) but no significant difference in estimated blood loss (132 vs 150 mL) or mean operative time (118 vs 100 minutes) between the high- and low-risk groups, respectively. The overall complication rate was similar between the high-risk (12.1%) and low-risk (12.3%) groups (P = .41). The stone-free rate for the high-risk group was 61% compared with 92% for the low-risk group (P = .028).
CONCLUSIONS: PCNL can be safely performed in the high-risk preoperative patient population. 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2009        PMID: 19781744     DOI: 10.1016/j.urology.2009.06.064

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


  8 in total

1.  Comparison of intraoperative and postoperative complications based on ASA risks in patients who underwent percutaneous nephrolithotomy.

Authors:  Hüseyin Buğra Karakaş; İzzet Çiçekbilek; Adem Tok; Tamer Alışkan; Bülent Akduman
Journal:  Turk J Urol       Date:  2016-09

2.  Retrograde intrarenal surgery by flexible ureteroscope in patients with spinal deformities.

Authors:  Fazli Polat; Suleyman Yesil
Journal:  J Spinal Cord Med       Date:  2016-02-23       Impact factor: 1.985

3.  [Complications in percutaneous lithotomy].

Authors:  M Ritter; M-C Rassweiler; M S Michel
Journal:  Urologe A       Date:  2014-07       Impact factor: 0.639

4.  Transient cessation of antiplatelet medication before percutaneous stone surgery: does it have any safety concern on bleeding related problems?

Authors:  Cahit Sahin; Utku Can; Bilal Eryildirim; Kemal Sarica
Journal:  Urolithiasis       Date:  2016-09-27       Impact factor: 3.436

5.  The learning curve in minimally invasive percutaneous nephrolitholapaxy: a 1-year retrospective evaluation of a novice and an expert.

Authors:  David Schilling; Georgios Gakis; Ute Walcher; Arnulf Stenzl; Udo Nagele
Journal:  World J Urol       Date:  2010-04-18       Impact factor: 4.226

6.  The effect of delayed percutaneous nephrolithotomy on the risk of bacteremia and sepsis in patients with neuromuscular disorders.

Authors:  Jairam R Eswara; Hang Lee; Stephen P Dretler; Dianne Sacco
Journal:  World J Urol       Date:  2013-02-27       Impact factor: 4.226

7.  Renal access through the inferior calyx is associated with higher risk of severe bleeding after percutaneous nephrolithotomy.

Authors:  Jing Tan; Binghai Chen; Leye He; Guangming Yin; Zhiqiang Jiang; Kun Yao; Xianzheng Jiang
Journal:  Arch Med Sci       Date:  2015-04-23       Impact factor: 3.318

8.  Prospective evaluation of complications using the modified Clavien grading system, and of success rates of percutaneous nephrolithotomy using Guy's Stone Score: A single-center experience.

Authors:  Swarnendu Mandal; Apul Goel; Rohit Kathpalia; Satyanarayan Sankhwar; Vishwajeet Singh; Rahul J Sinha; Bhupender P Singh; Divakar Dalela
Journal:  Indian J Urol       Date:  2012-10
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.